Mifepristone

The Washington Post’s resident “fact-checker” Glenn Kessler ran circles around himself this week when he tried to undermine the most comprehensive U.S. study on the drug regimen responsible for more than half of the nation’s abortions.

The Ethics and Public Policy Center, a think tank that says it opposes “the extreme progressive agenda while building consensus of conservatives,” recently issued a report on a key abortion medication, mifepristone, that it says raises questions about its safety. After analyzing insurance claims for more than 865,000 prescribed mifepristone abortions, the group said it had determined that almost 11 percent of women experienced a “serious adverse event,” much higher than an overall 0.5 percent rate found in clinical studies.

The Trump administration asked a federal judge on Monday to dismiss a lawsuit that seeks to sharply restrict access to the abortion pill mifepristone — taking the same position as the Biden administration in a closely watched case that has major implications for abortion access.

The Trump administration is asking a federal judge in Texas to dismiss a case that aims to restrict access to the abortion drug mifepristone. 

The request continues the Biden administration's position in defense of the drug: that Texas isn't the proper venue for the lawsuit.

Democrats and corporate media spent much of the 2024 election cycle trying to pin deaths directly linked to the abortion pill on pro-life policies. Their lies and deceptions primarily centered on the story of Amber Thurman, a Georgia woman who died alongside her twin babies after suffering complications stemming from the abortion pill.

Democratic and leftist groups are gaming out how to resist and prepare for former President Trump’s possible return to the White House, including blue state governors stockpiling abortion pills.

For almost a quarter century, the Food and Drug Administration has persistently bent the rules to approve the mifepristone-based chemical-abortion pill known as RU-486 on a fast-track basis and then strip away safeguards regarding its distribution, sometimes using pretexts such as the Covid pandemic. It has done so while playing bureaucratic games to evade judicial review and disregarding the 176-year-old federal statutory ban on sending abortion drugs in the mail.

A unanimous U.S. Supreme Court on Thursday preserved widespread access to a popular medication abortion pill, the court’s first abortion-related decision since overturning Roe v. Wade two years ago.

The same Supreme Court that overruled Roe vs. Wade two years ago on Thursday followed well-established constitutional principles to dismiss a lawsuit that sought to restrict the availability of mifepristone, a drug used to medically induce abortions. The bottom line is that the decision upholds the Food and Drug Administration’s rules for mifepristone. This is crucial for reproductive rights; it is estimated that 63% of all U.S. abortions are now medically induced rather than being performed surgically.